-- TD经济分析师玛丽亚·索洛维耶夫(Maria Soloviev)在周五公布2月份零售销售数据后表示,消费者在2月份再次展现了“稳健”的消费表现,初步迹象表明3月份的消费势头将延续。但3月份通胀率飙升,表明部分增长动力并非源于全面需求增长,而是由物价上涨推动。 她在分析周五公布的数据时指出,TD内部支出数据显示,3月份可自由支配支出有所放缓。 索洛维耶夫表示,能源价格上涨将削弱购买力,但TD预计这不会对国内需求造成实质性削弱,其影响已包含在TD的预期之中。她补充说,加上人口增长疲软和贸易相关不利因素的拖累,预计今年经济增长速度将低于趋势水平。 TD指出,2月份零售销售额环比增长0.7%,连续第二个月保持增长势头。这一数字低于加拿大统计局此前预估的0.9%的增幅。从数量上看,活动环比仅增长0.3%,增幅较为温和,表明整体增长主要受价格上涨推动。 展望未来,加拿大统计局的初步估计显示,3月份活动环比将进一步增长0.6%。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.